BridgeBio Pharma is a biotech company that specializes in discovering, developing and delivering medicines for genetic diseases. They have a range of 30 programs in development, from early discovery to late-stage, with several products in clinical trials, such as BBP-265 and BBP-831. The company also has collaborations with several research institutions and universities.